Abbott offers a broad infectious disease menu of assays that delivers trusted results. Our highly sensitive and specific tests help physicians make timely, informed decisions with confidence.
For in vitro diagnostic use.
| Hepatitis |
|---|
| Anti-HAV IgG |
| Anti-HAV IgM |
| Anti-HBc IgM |
| Anti-HBe |
| HBeAg |
| Anti-HBs |
| HBsAg (Quantitative) |
| Anti-HCV |
| HCV Ag |
| HBsAg (Qualitative Conf.) |
| Other Infectious Disease |
|---|
| Chagas |
| EBV EBNA-1-IgG |
| EBV VCA IgG |
| EBV VCA IgM |
| Syphilis TP |
| RETROVIRUS |
| Anti-HTLV-I/HTLV-II |
| TORCH |
| CMV IgG |
| CMV IgG Avidity |
| CMV IgM |
| HSV-1 IgG |
| HSV-2 IgG |
| Rubella IgG |
| Rubella IgM |
| Toxo IgG |
| Toxo IgG Avidity |
| Toxo IgM |
Diagnostics at Abbott offers a complete portfolio of integrated solutions including Core Laboratory, Molecular, Point of Care, Rapid Diagnostics and Transfusion Medicine.
It’s a never-ending challenge to keep up with the evidence associated with infectious diseases and their constant variations to ensure valid virus detection.
Serology testing is an important next step in combating the COVID-19 pandemic. Our automated lab-based test detects the human antibody response, IgG, to the novel coronavirus. Antibody testing provides additional options to test patients and conduct research.
Screening for TORCH infections early in pregnancy can help reduce the risk of transmitting an infection from the mother to the baby. Explore how Abbott's TORCH panel can help confidently detect infections and optimize efficiencies in your laboratory.
With the availability of new and highly effective therapies, laboratories need to overcome diagnostic challenges to help identify and manage the estimated 67 million people worldwide who may be unaware they are infected with HCV. 1-2 A healthier future without Hepatitis C is now possible. See how the diagnostic solutions from Abbott can support laboratories in making elimination a reality.
Abbott's scientists and market experts are continuously working together to solve today's challenges, understand future needs and eliminate gaps in the diagnosis of infectious disease patients and in our overall health care community.
Our menu offerings span tests designed to help diagnose HIV and HTLV infections.
Abbott offers numerous congenital testing options, helping health care professionals identify the presence of infection in patients.
Abbott has a range of infectious disease assays that includes tests for EBV and Syphilis.
Learn more about our impact on infectious disease by viewing our webinars.
Learn about Liver Disease Analytes and how they are used to help detect and monitor hepatic disease.
With Global Viral Surveillance, Abbott is committed to evaluating and solving some of today's toughest infectious disease challenges.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimised for your screen size.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
